Bloomberg News

Cochlear Recall of Ear Implant May Cost A$100 Million, UBS Says

October 17, 2011

Oct. 17 (Bloomberg) -- Cochlear Ltd.’s recall of its N5 ear implants may cost about A$100 million, UBS AG health-care analysts Andrew Goodsall and Dan Hurren said in a report today.

To contact the editor responsible for this story: Jason Gale at j.gale@bloomberg.net


Race, Class, and the Future of Ferguson
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus